Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | DHCR24 | Q15392 | 10/20 | 0.77 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 2/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | OSBP | P22059 | 1/20 | 0.50 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.50 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.48 |
| ▸ | GPR183 | P32249 | 1/20 | 0.46 |
| ▸ | RORA | P35398 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL187737 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL14360754 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL15529878 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL5571689 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28606202 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL25035233 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL1957035 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28186368 | 0.92 | MEN1 (0.85) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12869826 | 0.91 | MEN1 (0.83) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12869831 | 0.91 | MEN1 (0.83) | USP2MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| CN-119591676-A | Lipopeptide HIV membrane fusion inhibitor and pharmaceutical application | 中国医学科学院病原生物学研究所 | 2025-03-11 | — | — | CN | claimed |
| CN-119192302-A | Method for designing polypeptide drug and application | 中国医学科学院病原生物学研究所 | 2024-12-27 | — | — | CN | claimed |
| US-20240408019-A1 | METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPs) AND LNPs OBTAINED WITH THE SAME | SANOFI PASTEUR INC. | 2024-12-12 | — | — | US | claimed |
| WO-2024192623-A1 | BROAD-SPECTRUM VIRAL MEMBRANE FUSION INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 河南真实生物科技有限公司 | 2024-09-26 | — | — | WO | claimed |
| EP-4412590-A1 | METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPS) AND LNPS OBTAINED WITH THE SAME | Sanofi (FR) | 2024-08-14 | — | — | EP | claimed |
| CN-118302155-A | Method for freezing and freeze-drying Lipid Nanoparticles (LNPs) and LNPs obtained thereby | 赛诺菲 | 2024-07-05 | — | — | CN | claimed |
| WO-2024099428-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | 中国医学科学院病原生物学研究所 | 2024-05-16 | — | — | WO | claimed |
| US-20230398211-A1 | Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof | SANOFI PASTEUR (FR) | 2023-12-14 | — | — | US | claimed |
| CN-117186187-A | Anti-respiratory syncytial virus membrane fusion inhibitor and pharmaceutical application thereof | 中国医学科学院病原生物学研究所 | 2023-12-08 | — | — | CN | claimed |
| CN-116847830-A | Liposomes containing TLR4 agonists, their preparation and use | 赛诺菲巴斯德有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116789761-A | Broad-spectrum coronavirus membrane fusion inhibitor and pharmaceutical application thereof | 成都奥达生物科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| EP-4237085-A1 | LIPOSOMES CONTAINING TLR4 AGONIST, PREPARATION AND USES THEREOF | Sanofi Pasteur (FR) | 2023-09-06 | — | — | EP | claimed |
| CN-116444644-A | Broad-spectrum virus membrane fusion inhibitor and preparation method and application thereof | 河南真实生物科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| WO-2023057444-A1 | METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPs) AND LNPs OBTAINED WITH THE SAME | SANOFI (FR) | 2023-04-13 | — | — | WO | claimed |
| CN-115724919-A | Novel membrane fusion inhibitor for strongly inhibiting AIDS virus and drug-resistant strains thereof and pharmaceutical application thereof | 中国医学科学院病原生物学研究所 | 2023-03-03 | — | — | CN | claimed |
| CN-114478709-A | Long-acting hepatitis virus entry inhibitor | 成都奥达生物科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| WO-2022090359-A1 | LIPOSOMES CONTAINING TLR4 AGONIST, PREPARATION AND USES THEREOF | SANOFI PASTEUR (FR) | 2022-05-05 | — | — | WO | claimed |
| CN-114075276-A | Long-acting relaxin 2 analogue | 成都奥达生物科技有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-114075275-A | Long-acting insulin analogue | 成都奥达生物科技有限公司 | 2022-02-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398211-A1 | Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof | TLR4, TLR1, TLR7 | USP2 3893/4885MEN1 4220/4885KMT2A 3215/4885 |
| US-20240408019-A1 | METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPs) AND LNPs OBTAINED WITH THE SAME | CETP, LIPA, AUP1 | USP2 3827/4885MEN1 2725/4885KMT2A 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.